Moderna Injects AI at Scale to Transform Its Global Operations
Moderna, known globally for its pioneering mRNA COVID-19 vaccine, is now driving a bold transformation by embedding artificial intelligence (AI) across its operations.
- The company has partnered with OpenAI, adopting and customizing thousands of GPTs (Generative Pre-Trained Transformers) to handle work once managed by human teams.
- This transformation has already influenced organizational structures, workflows, and even staffing decisions.
A Strategic Partnership with OpenAI
Moderna’s AI journey began in 2023 when it first leveraged OpenAI’s API to build an internal chatbot for employee support.
- By April 2024, this collaboration deepened into a formal partnership, allowing employees access to ChatGPT Enterprise for enterprise-wide adoption.
- The goal was to accelerate the development of life-saving treatments, aligning with both companies’ missions in healthcare and technology.
Dose ID GPT: AI in Clinical Decision-Making
One of the earliest AI tools developed under this initiative was Dose ID GPT, designed to optimize vaccine dosing strategies.
- It was trained on Moderna’s internal dose selection criteria, helping clinical teams process massive datasets with greater efficiency, accuracy, and safety.
- According to Moderna’s senior director of clinical development, the model enhances how they evaluate and recommend dose protocols.
AI Embedded Across Business Functions
By April 2024, Moderna had already integrated over 750 GPTs across key business areas.
- These included legal, research, manufacturing, and commercial operations, where GPTs function as intelligent assistants.
- Each GPT is custom-built, providing personalized support to employees and improving operational outcomes.
Scaling to Over 3,000 GPTs in One Year
In just a year, Moderna expanded from 750 to over 3,000 deployed GPTs, many of which now operate in interconnected workflows.
- For instance, a central HR GPT filters employee queries, routing them to specialized GPTs for topics like benefits, performance management, and equity.
- This layered structure increases response speed and reduces manual workload across departments.
HR and Tech: A Merged Leadership Model
As AI became foundational, Moderna merged its Human Resources and Technology departments under a unified leadership.
- Tracey Franklin, formerly HR head, now holds the title Chief People and Digital Technology Officer, reflecting the evolving nature of workforce management.
- She is now redesigning teams based on what tasks are best automated versus those requiring human insight.
Workforce Restructuring Driven by AI
This organizational shift has prompted a reimagining of roles throughout the company.
- New roles are being created, outdated ones are being eliminated, and others are being redefined based on AI’s capabilities.
- Franklin emphasized this approach is part of a strategy to maximize human-AI collaboration rather than simply reduce headcount.
Layoffs and the Digital Team Reduction
In February 2024, Moderna laid off approximately 50 employees from its digital technology division, representing a 10% reduction.
- While the company did not confirm whether these layoffs were directly tied to AI automation, the timing aligns with its increasing AI integration.
- This suggests a shift toward leaner digital teams enhanced by intelligent systems.
A Blueprint for AI-First Enterprises
Moderna’s rapid AI adoption positions it as a blueprint for future-forward biotech companies.
- With over 3,000 GPTs actively streamlining operations and transforming job roles, Moderna is leading by example in what an AI-first workplace can look like.
- The company’s continued evolution hints at broader industry shifts, where efficiency, automation, and AI-assisted decision-making become the new norm.
